Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,076 | 106 | 75.5% |
| Consulting Fee | $1,000 | 1 | 24.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Clovis Oncology, Inc. | $1,086 | 2 | $0 (2017) |
| Elekta, Inc. | $357.16 | 6 | $0 (2018) |
| Amgen Inc. | $258.90 | 9 | $0 (2023) |
| ASD Specialty Healthcare, LLC | $240.68 | 4 | $0 (2018) |
| Celgene Corporation | $205.25 | 4 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $192.89 | 8 | $0 (2023) |
| Eisai Inc. | $184.82 | 4 | $0 (2023) |
| PFIZER INC. | $173.88 | 8 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $162.10 | 8 | $0 (2023) |
| Merck Sharp & Dohme LLC | $146.20 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.39 | 1 | ABBVIE INC. ($18.39) |
| 2023 | $485.29 | 19 | Novartis Pharmaceuticals Corporation ($82.41) |
| 2022 | $1,227 | 54 | EISAI INC. ($162.44) |
| 2019 | $312.12 | 13 | Amgen Inc. ($129.71) |
| 2018 | $526.05 | 10 | Elekta, Inc. ($357.16) |
| 2017 | $1,507 | 10 | Clovis Oncology, Inc. ($1,086) |
All Payment Transactions
107 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: ONCOLOGY | ||||||
| 07/27/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $29.63 | General |
| Category: ONCOLOGY | ||||||
| 07/27/2023 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Oncology | ||||||
| 07/20/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Oncology | ||||||
| 07/06/2023 | Genentech USA, Inc. | Alecensa (Biological), Gavreto, Rozlytrek | Food and Beverage | In-kind items and services | $27.69 | General |
| Category: BioOncology | ||||||
| 06/29/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $32.06 | General |
| Category: ONCOLOGY | ||||||
| 06/22/2023 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: Oncology | ||||||
| 06/15/2023 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $24.99 | General |
| Category: Hematology | ||||||
| 06/08/2023 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $28.32 | General |
| Category: Hematology | ||||||
| 05/25/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $24.85 | General |
| Category: Oncology | ||||||
| 05/18/2023 | PFIZER INC. | INLYTA (Drug), BAVENCIO, XTANDI | Food and Beverage | In-kind items and services | $33.90 | General |
| Category: ONCOLOGY | ||||||
| 04/19/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $22.38 | General |
| Category: Oncology | ||||||
| 03/30/2023 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Oncology | ||||||
| 03/09/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: ONCOLOGY | ||||||
| 02/09/2023 | Organon LLC | — | Food and Beverage | In-kind items and services | $19.16 | General |
| 01/19/2023 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $34.25 | General |
| Category: Oncology | ||||||
| 01/14/2023 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $23.00 | General |
| 01/12/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: ONCOLOGY | ||||||
| 01/11/2023 | SOBI, INC | Doptelet (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 01/05/2023 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Oncology | ||||||
| 12/27/2022 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: ONCOLOGY | ||||||
| 12/14/2022 | Janssen Biotech, Inc. | — | Food and Beverage | In-kind items and services | $14.01 | General |
| 12/09/2022 | AVEO Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Oncology | ||||||
| 12/08/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: ONCOLOGY | ||||||
| 12/08/2022 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $27.22 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 12 | 26 | $241.69 | $178.08 |
| 2022 | 6 | 75 | 105 | $16,236 | $6,426 |
| 2021 | 1 | 12 | 29 | $4,698 | $1,507 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 12 | 26 | $241.69 | $178.08 | 73.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $5,166 | $2,066 | 40.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 16 | $4,560 | $1,820 | 39.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 16 | $3,232 | $1,292 | 40.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $2,750 | $994.64 | 36.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 12 | 24 | $384.00 | $183.12 | 47.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 14 | 24 | $144.00 | $70.68 | 49.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 29 | $4,698 | $1,507 | 32.1% |
About Dr. Mitchell Berger, MD
Dr. Mitchell Berger, MD is a Hematology & Oncology healthcare provider based in Dalton, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750321956.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mitchell Berger, MD has received a total of $4,076 in payments from pharmaceutical and medical device companies, with $18.39 received in 2024. These payments were reported across 107 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($3,076).
As a Medicare-enrolled provider, Berger has provided services to 99 Medicare beneficiaries, totaling 160 services with total Medicare billing of $8,111. Data is available for 3 years (2021–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Dalton, GA
- Active Since 06/07/2006
- Last Updated 02/03/2022
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1750321956
Products in Payments
- Rubraca (Drug) $1,086
- Mosaiq (Device) $357.16
- Lenvima (Drug) $184.82
- KISQALI (Drug) $148.93
- KEYTRUDA (Biological) $146.20
- GILOTRIF (Drug) $135.87
- Revlimid (Drug) $134.40
- Neulasta (Biological) $129.71
- INLYTA (Drug) $122.79
- Aliqopa (Drug) $102.45
- ENHERTU (Drug) $58.13
- Nplate (Biological) $52.34
- Trodelvy (Drug) $50.26
- MONJUVI (Drug) $49.74
- OPDIVO (Biological) $49.64
- TIBSOVO (Drug) $47.29
- Pomalyst (Drug) $45.86
- BRAFTOVI (Drug) $45.06
- IMFINZI (Drug) $36.68
- TAGRISSO (Drug) $35.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Dalton
Mrs. Monica Verma, Md, MD
Hematology & Oncology — Payments: $11,131
Mr. Hosam Saad-Naguib, Md, MD
Hematology & Oncology — Payments: $4,923
James Turner, M.d, M.D
Hematology & Oncology — Payments: $3,594
Dr. Lisa Duhaime, M.d, M.D
Hematology & Oncology — Payments: $2,912
Dr. Atulkumar Patel, Md, MD
Hematology & Oncology — Payments: $2,395
Michona Robinson, Fnp, FNP
Hematology & Oncology — Payments: $1,009